Skip to content
Search

Latest Stories

Pharmacies trying to profiteer from pandemic will face action, regulators warn

Any pharmacy or pharmacy owner found to have breached competition or consumer protection law risks facing action for damaging public confidence, the pharmacy regulator has warned.

The General Pharmaceutical Council (GPhC) and the Competition and Markets Authority (CMA) have written a joint letter to superintendent pharmacists and pharmacy contractors asking them to ensure they do not damage public confidence.


The letter said that “a small minority of pharmacies are seeking to benefit from the coronavirus pandemic by charging unjustifiably high prices for essential products – including hand sanitiser, face masks and paracetamol – which continue to be in very high demand.”

“Whilst the numbers involved may be small, the issue has been prominent in the public eye,” the letter added.

The pharmacy regulator said it was engaging with the CMA to ensure that the two bodies could use their “respective roles and powers in a complementary and proportionate way” while dealing with complaints about extortionate pricing.

The GPhC clarified that while it usually doesn't take action on matters that are purely commercial in nature and have no medicinal or practice-related element, this was a broader issue that would impact on public confidence.

As the country’s lead competition and consumer authority, the CMA said it was concerned about any price charged by a pharmacy for an essential product that is higher than the ‘normal’ price as a result of percentage mark-up on the wholesale price it has paid.

It had recently announced the launch of an investigation against four convenience stores and pharmacies over suspected excessive and unfair pricing of hand sanitiser products during the Covid-19 pandemic.

The letter stated that consequences of the CMA reaching a final finding that competition law has been infringed are potentially significant and include the possibility of financial penalties.

Pharmacies experiencing large price rises or other unfair practices from their suppliers have been asked to report this to the CMA by using its online complaints form.

More For You

NHS England to halve workforce to cut costs

“We are entering a period of critical transformation for our NHS," says Wes Streeting.

Getty Images

NHS England to halve workforce in biggest reshaping in over a decade

NHS England and the Department of Health and Social Care (DHSC) are set for significant downsizing as they strengthen collaboration under the 10-Year Health Plan to build a future-fit health service.

As part of this transformation, the NHSE workforce is expected to be reduced by up to 50% to cut costs and eliminate duplication with DHSC officials.

Keep ReadingShow less
Discrimination: Asian and Black patients report lack of trust in primary care providers

Ethnic minority groups had worse experiences in their communication with their GP practice and felt taken less seriously

Getty Images

Survey reveals alarming rates of ethnic discrimination in NHS primary care

A recent survey by the NHS Race and Health Observatory has highlighted a worrying lack of trust in NHS primary care services among Black, Asian, and ethnic minority patients, who reported experiencing “racial or ethnic discrimination.”

Out of 2,680 survey respondents, only 55% reported trusting primary care providers to meet their health needs most or all of the time

Keep ReadingShow less
Swizzels’ Easter range, including Squashies Drumchick and Sweet Shop Favourite tubs

PDA members will get the chance to vote from this week

Pic credit: iStock

PDA to inform its members to vote “no” in Royal College of Pharmacy proposals

A vote to create a potential Royal College of Pharmacy needs to be called off as the current proposals would lead to “irreversible change to the identity and purpose” of the sector’s professional leadership body, according to the Pharmacy Defence Association (PDA).

From March 13th to March 24th, The Royal Pharmaceutical Society’s members will take part in a Special Resolution Vote (SRV) which seeks to amend the Society’s Royal Charter to facilitate its transition to a Royal College and registered charity.

Keep ReadingShow less
Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less